These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1576 related items for PubMed ID: 26877211

  • 1. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS, Stella F, Radanovic M, Aprahamian I, Bertollucci PH, Forlenza OV.
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D, Broggio E, Gambina G, Maida C, Gaudio MR, Corbo RM.
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC, Gatzima O, Daniilidou M, Lazarou E, Bamidis PD, Verykouki E, Iakovidou-Kritsi Z, Tsolaki M.
    Neurodegener Dis; 2018 Dec; 18(4):216-224. PubMed ID: 30205398
    [Abstract] [Full Text] [Related]

  • 4. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O, Alzheimer’s Disease Neuroimaging Initiative.
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [Abstract] [Full Text] [Related]

  • 6. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC, Gaser C, Franke K, Alzheimer’s Disease Neuroimaging Initiative.
    PLoS One; 2016 Oct; 11(7):e0157514. PubMed ID: 27410431
    [Abstract] [Full Text] [Related]

  • 7. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
    Cho H, Kim YE, Chae W, Kim KW, Kim JW, Kim HJ, Na DL, Ki CS, Seo SW.
    Sci Rep; 2020 Aug 07; 10(1):13365. PubMed ID: 32770103
    [Abstract] [Full Text] [Related]

  • 8. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD, Fisk JD, Rockwood K.
    Dement Geriatr Cogn Disord; 2003 Aug 07; 15(1):1-5. PubMed ID: 12457072
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.
    Dement Geriatr Cogn Disord; 2007 Aug 07; 23(5):327-33. PubMed ID: 17374951
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.
    Dement Geriatr Cogn Disord; 2006 Aug 07; 22(1):73-82. PubMed ID: 16699282
    [Abstract] [Full Text] [Related]

  • 11. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.
    J Clin Psychiatry; 2012 Dec 07; 73(12):1555-62. PubMed ID: 23146133
    [Abstract] [Full Text] [Related]

  • 12. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.
    Neurology; 2004 Sep 14; 63(5):816-21. PubMed ID: 15365129
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.
    Am J Pathol; 1996 Jun 14; 148(6):2083-95. PubMed ID: 8669492
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X, Fernández Martínez M, Galdos Alcelay L, Molano Salazar A, Bereincua Gandarias R, Inglés Borda S, Gómez Busto F, Uterga Valiente JM, Indakoetxea Juanbeltz B, Gómez Beldarraín MA, de Pancorbo MM.
    Dement Geriatr Cogn Disord; 2011 Jun 14; 32(5):332-41. PubMed ID: 22311091
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZ, Stella F, Machado-Vieira R, Gattaz WF.
    Bipolar Disord; 2016 Feb 14; 18(1):63-70. PubMed ID: 26876913
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ.
    J Neurol Neurosurg Psychiatry; 2011 Oct 14; 82(10):1149-56. PubMed ID: 21493755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.
    Neurosci Lett; 2010 Oct 08; 483(1):62-6. PubMed ID: 20678545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.